Biometrics: a ‘cheat-proof’ exam?
pharmafile | July 21, 2008 | Feature | Business Services, Sales and Marketing |Â Â biometris, pharma, recruitment, salesÂ
Related Content
Amphista doses first patient in AML trial of protein degrader
Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an …
Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …
AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …
